Haohao Liu

Title: Haohao Liu: Innovator in Genetically-Engineered Strains for Steroidal Compounds

Introduction

Haohao Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of genetically-engineered strains for the preparation of steroidal compounds. With a total of 2 patents, his work has the potential to revolutionize the production processes in the pharmaceutical industry.

Latest Patents

Haohao Liu's latest patents include a genetically-engineered mycobacterium strain and a use thereof in the preparation of steroidal compounds. This invention relates to a genetically-engineered strain that lacks acyl-CoA dehydrogenase genes fadE31, fadE32, and fadE33. The strain is designed to improve the production efficiency and product quality of steroid drugs while reducing energy consumption and production costs.

Another notable patent involves a hydroxyacyl-coenzyme A dehydrogenase gene and an acyl-coenzyme A thiolase gene. This invention constructs genetically engineered strains that are utilized in the preparation of various steroidal compounds. The advantages of this invention include mild reaction conditions, environmental friendliness, and significant economic and social benefits.

Career Highlights

Haohao Liu is affiliated with the East China University of Science and Technology, where he conducts his research and development activities. His innovative work in biotechnology has garnered attention and respect within the scientific community.

Collaborations

Some of his notable coworkers include Fengqing Wang and Dongzhi Wei, who have collaborated with him on various research projects.

Conclusion

Haohao Liu's contributions to the field of biotechnology through his patented inventions demonstrate his commitment to advancing the production of steroidal compounds. His work not only enhances production efficiency but also promotes environmentally sustainable practices in the pharmaceutical industry.